Hepatitis E: Diagnostic and Therapeutic Challenges
Journal Title: Archives of Hepatitis Research - Year 2017, Vol 3, Issue 1
Abstract
HEV infection may be symptomatic or asymptomatic that has affected about one-third of world population with a case fatality rate of 1-2%, including 20-30% of infected pregnant women [3-5]. Though inherently hepatotropic causing fulminant liver failure and cirrhosis, HEV has recently evolved with extra hepatic manifestations where biochemical/serological evidence of infection is often modest or absent [6-8]. HEV is a non-enveloped virus with a positive single-strand RNA genome (~7.2 kb) with three partially overlapped open reading frames (ORF1, ORF2 and ORF3) [9]. Of the several recognized genotypes, HEV1 and HEV2 are known to infect humans only while HEV3, HEV4 and HEV7 are infectious to humans and other mammalian species, such as swine, boar and dear [10]. On the other hand, genotypes HEV5 and HEV6 have been detected in animals only, and their transmission to humans are not established [10]. Further, while HEV1 is endemic in Asia and Middle East, HEV2 is prevalent in African and South American countries. Contrarily, HEV3 and HEV4 are less pathogenic, and are mainly confined to Eastern Asian countries, Eastern and Western Europe, and North America [2]. Notably, in the Western countries, autochthonous HEV3 infection is attributed to sporadic cases of acute hepatitis, potentially linked to pork consumption [2].
Authors and Affiliations
Parvez Mohammad K
Keywords
Related Articles
- EP ID EP559375
- DOI 10.17352/ahr.000009
- Views 31
- Downloads 0
The Potential of Liver Fibrosis Indexes/Scores for the Screening of Cryptic Liver Fibrosis in Patients with NASH Risk Factors: A Case Report
The unintentional discovery of cirrhosis in a patient with prostate cancer lead us to enquire if some of the indexes/scored designed for the evaluation of liver fibrosis/cirrhosis, in Chronic Hepatitis C patients, could...
Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of fatty liver, characterized by the accumulation of fat in the hepatocytes in the absence of alcohol consumption. The spectrum of th...
Non-Alcoholic Fatty Liver Disease Frequency among Healthy Blood Donors in the West of Iran
Objectives: To investigate the prevalence of NAFLD as well as the determination of associated metabolic abnormalities in Iranian blood donors. The aim of this study was to review cases of non-alcoholic fatty liver diseas...
Relative and combined Effects of Ethanol and Hepatitis C Virus Infection on Serum Interleukin-17 Levels
Background: Interleukin-17 (IL-17) is involved in neutrophil recruitment and may contribute to the progression from fatty liver to steatohepatitis. Its role in alcoholics and in HCV-infected patients is not clear, lower-...
Management of Hepatitis C Infection with Direct Action Antiviral Drugs (DAA)**
Several new direct action antiviral drugs (DAA) against the HCV virus (HCV) are approved and marketed. The combination of DAA with pegylated interferon and ribavirin (PR) is only recommended to patients with tolerance to...